Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues
- PMID: 17644553
- DOI: 10.1136/ard.2006.068882
Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues
Abstract
Osteoarthritis is a chronic disease characterised by irreversible damage to joint structures, including loss of articular cartilage, osteophyte formation, alterations in the subchondral bone and synovial inflammation. Pain, functional disability and impairment of health-related quality of life are major complaints in patients with osteoarthritis. Several compounds have been investigated for their positive effects on the relief of clinical symptoms and improvement of structural changes in osteoarthritis. It has been shown that chondroitin sulphate interferes with the progression of structural changes in joint tissues and is used in the management of patients with osteoarthritis. This review summarises data from relevant reports describing the mechanisms of action of chondroitin sulphate involved in the beneficial effects of the drug.
Similar articles
-
Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review.Osteoarthritis Cartilage. 2010 Jun;18 Suppl 1:S7-11. doi: 10.1016/j.joca.2010.01.015. Epub 2010 Apr 27. Osteoarthritis Cartilage. 2010. PMID: 20399897 Review.
-
Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence?Curr Med Res Opin. 2013 Mar;29(3):259-67. doi: 10.1185/03007995.2012.753430. Epub 2013 Jan 31. Curr Med Res Opin. 2013. PMID: 23186102 Review.
-
The combined therapy with chondroitin sulfate plus glucosamine sulfate or chondroitin sulfate plus glucosamine hydrochloride does not improve joint damage in an experimental model of knee osteoarthritis in rabbits.Eur J Pharmacol. 2017 Jan 5;794:8-14. doi: 10.1016/j.ejphar.2016.11.015. Epub 2016 Nov 12. Eur J Pharmacol. 2017. PMID: 27845067
-
Changes in the chondroitin sulfate-rich region of articular cartilage proteoglycans in experimental osteoarthritis.Biochim Biophys Acta. 1985 Jun 18;840(2):228-34. doi: 10.1016/0304-4165(85)90123-0. Biochim Biophys Acta. 1985. PMID: 3922432
-
Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis.Int J Mol Sci. 2018 Feb 27;19(3):674. doi: 10.3390/ijms19030674. Int J Mol Sci. 2018. PMID: 29495538 Free PMC article. Review.
Cited by
-
Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis?BMC Musculoskelet Disord. 2014 Sep 27;15:318. doi: 10.1186/1471-2474-15-318. BMC Musculoskelet Disord. 2014. PMID: 25261974 Free PMC article.
-
Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis.J Neuroimmunol. 2010 Jun;223(1-2):55-64. doi: 10.1016/j.jneuroim.2010.04.002. J Neuroimmunol. 2010. PMID: 20434781 Free PMC article.
-
Nanoparticle-Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy.Nanomicro Lett. 2021 Jun 23;13(1):149. doi: 10.1007/s40820-021-00670-y. Nanomicro Lett. 2021. PMID: 34160733 Free PMC article. Review.
-
Porcine-Derived Chondroitin Sulfate Sodium Alleviates Osteoarthritis in HTB-94 Cells and MIA-Induced SD Rat Models.Int J Mol Sci. 2025 Jan 9;26(2):521. doi: 10.3390/ijms26020521. Int J Mol Sci. 2025. PMID: 39859238 Free PMC article.
-
Immunomodulatory and anti-inflammatory effects of chondroitin sulphate.J Cell Mol Med. 2009 Aug;13(8A):1451-63. doi: 10.1111/j.1582-4934.2009.00826.x. Epub 2009 Jun 11. J Cell Mol Med. 2009. PMID: 19522843 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical